Submit an order form online, via fax, or by email.

If you have questions, we are here to help. Call Foundation Medicine Client Services at 888.988.3639 between 8:00 am ET and 8:00 pm ET, Monday through Friday. You can also send us an email and a representative will respond during regular business hours.

Ordering Overview

To order a Foundation Medicine test for a patient

Online Ordering

  1. Login or sign up for a Foundation Medicine account.

Order by Fax

  1. Download and complete the appropriate Test Requisition Form below. Follow instructions here for filling out the form.
  2. Fax the requisition form, along with the pathology report and insurance information, to 617.418.2290.

To order a specimen kit for any of our tests

Please contact a Client Services Representative at 888.988.3639 or client.services@foundationmedicine.com.

If sending a solid tumor specimen, Foundation Medicine will complete the rest of the specimen retrieval process. We will contact the pathologist and send a Specimen Collection Kit with instructions for sample procurement and shipment.

If sending peripheral blood or bone marrow aspirate, please follow the specimen preparation instructions for liquid specimens.

FoundationOne CDx™

New FDA-Approved Broad Companion Diagnostic (CDx) for Solid Tumors with Medicare Coverage1

FoundationOne CDx helps inform treatment decisions, with insights specific to each patient’s cancer. Results from a single tissue sample (FFPE) identify multiple biomarkers to save time and tissue compared with sequential single-gene testing.

When submitting specimens to Foundation Medicine, please include the following items in the FoundationOne CDx Specimen Kit:

  • Appropriate specimen per FoundationOne CDx Specimen Instructions labeled with two patient-specific identifiers
  • Completed Test Requisition Form
  • Copy of recent pathology/cytology reports

Easy-to-understand test results are available online or via fax in less than 14 days. Reports match cancer patients’ molecular information with targeted therapies, immunotherapies, and clinical trials to expand treatment options.


1 Medicare and Medicare Advantage members have coverage of FoundationOne CDx in accordance with the Centers for Medicare and Medicaid Services (CMS) national coverage determination (NCD) criteria.

FoundationOne®

Patients with solid tumors can be tested with FoundationOne with an FFPE tissue sample. When submitting specimens to Foundation Medicine, please include the following items in the FoundationOne Specimen Kit:

  • Appropriate specimen per FoundationOne Specimen Collection Instructions labeled with two patient-specific identifiers
  • Completed Test Requisition Form
  • Copy of recent pathology/cytology reports

Easy-to-understand test results are available online or via fax in less than 14 days. Reports match cancer patients’ molecular information with targeted therapies, immunotherapies, and clinical trials to expand treatment options.

FoundationOne®Heme

Patients with hematologic malignancies and sarcomas can be tested with FoundationOneHeme, which is performed on FFPE, peripheral whole blood or bone marrow aspirate specimens. When submitting specimens to Foundation Medicine, please include the following items in the FoundationOneHeme Specimen Kit:

  • Appropriate specimen per FoundationOneHeme Specimen Collection Instructions, labeled with two patient-specific identifiers
  • Completed Test Requisition Form
  • Copy of recent pathology/cytology reports

Note for Bone Samples: Do not use strong acids to decalcify. Hydrochloric acid should be avoided; EDTA is recommended, and formic acid has mixed results. Place sample in decalcifying solution for minimal amount of time. Using a weaker acid and shorter time for decalcifying preserves the nucleic acid and increases likelihood for getting results on bone samples.

Easy-to-understand test results are available online or via fax in approximately 14 days. Reports match cancer patients’ molecular information with targeted therapies, immunotherapies, and clinical trials to expand treatment options.

FoundationACT®

Patients with solid tumors can be tested using our liquid biopsy, FoundationACT, which requires two tubes of peripheral whole blood. When submitting specimens to Foundation Medicine, please include the following items in the FoundationACT Specimen Kit:

  • Appropriate specimen per FoundationACT Specimen Collection Instructions (use only blood tubes provided in the kit)
  • Completed Test Requisition Form
  • Insurance information and available reports

Easy-to-understand test results are available online or via fax in less than 14 days. Reports match cancer patients’ molecular information with targeted therapies, immunotherapies, and clinical trials to expand treatment options.

FoundationFocus™ CDx BRCA

Ovarian cancer patients can be tested with FoundationFocus™ CDx BRCA with an FFPE tissue sample, when you are considering treatment with Rubraca® (rucaparib). FoundationFocus CDx BRCA is a companion diagnostic to Clovis Oncology's drug Rubraca, a poly (ADP-ribose) polymerase (PARP) inhibitor. When submitting specimens to Foundation Medicine, please include the following items in the FoundationFocus CDx BRCA Specimen Kit:

  • Appropriate specimen per FoundationFocus CDx BRCA Specimen Collection Instructions
  • Completed Test Requisition Form
  • Insurance information and available reports

Easy-to-understand test results are available online or via fax typically 2 weeks from receipt of specimen. Reports include BRCA1/2 alteration status (may be somatic or germline). Specimens that are found to have a deleterious BRCA alteration in their tumor tissue (tBRCA+) may be eligible for treatment with Rubraca (rucaparib) therapy.